Overview
To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
Description
Primary Objectives:
To assess the influence of smokeless tobacco products' modified risk claims on:
- Product demand (measured as willingness to pay in USD) using an experimental auction approach; and
- Perceived risk of tobacco-associated diseases as assessed using questionnaire-based measures.
Eligibility
Inclusion Criteria:
- Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
- Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
- Open to trying a non-combusted oral tobacco product.
- Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
- Have the ability to read, write, and communicate in English.
- Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure
Exclusion Criteria:
- Plan to quit smoking in the next 30 days.
- Use of smokeless tobacco at least weekly in the last 6 months.
- Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
- Unwilling or unable to follow protocol requirements.
- Pregnant or planning to become pregnant (by self report)